Evidence map›Paper›PMID 25789768›Full record

ArticlePloS one2015

Combinations of Ashwagandha leaf extracts protect brain-derived cells against oxidative stress and induce differentiation.

Navjot Shah, Rumani Singh, Upasana Sarangi, Nishant Saxena, Anupama Chaudhary, Gurcharan Kaur, Sunil C Kaul, Renu Wadhwa

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Antioxidants (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. International journal of molecular sciences · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Navjot ShahCell Proliferation Research Group and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305-8562, Japan.
Rumani SinghCell Proliferation Research Group and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305-8562, Japan.
Upasana SarangiCell Proliferation Research Group and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305-8562, Japan.
Nishant SaxenaCell Proliferation Research Group and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305-8562, Japan.
Anupama ChaudharyCell Proliferation Research Group and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305-8562, Japan.
Gurcharan KaurDepartment of Biotechnology, Guru Nanak Dev University, Amritsar 143005, India.
Sunil C KaulCell Proliferation Research Group and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305-8562, Japan.
Renu WadhwaCell Proliferation Research Group and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305-8562, Japan.
National Institute of Advanced Industrial Science and Technology · JPGuru Nanak Dev University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAshwagandha, a traditional Indian herb, has been known for its variety of therapeutic activities. We earlier demonstrated anticancer activities in the alcoholic and water extracts of the leaves that were mediated by activation of tumor suppressor functions and oxidative stress in cancer cells. Low doses of these extracts were shown to possess neuroprotective activities in vitro and in vivo assays. METHODOLOGY/PRINCIPAL

findingsWe used cultured glioblastoma and neuroblastoma cells to examine the effect of extracts (alcoholic and water) as well as their bioactive components for neuroprotective activities against oxidative stress. Various biochemical and imaging assays on the marker proteins of glial and neuronal cells were performed along with their survival profiles in control, stressed and recovered conditions. We found that the extracts and one of the purified components, withanone, when used at a low dose, protected the glial and neuronal cells from oxidative as well as glutamate insult, and induced their differentiation per se. Furthermore, the combinations of extracts and active component were highly potent endorsing the therapeutic merit of the combinational approach.

conclusionAshwagandha leaf derived bioactive compounds have neuroprotective potential and may serve as supplement for brain health.

Indexed as

AnimalsApoptosisCell DifferentiationCell Line, TumorCell SurvivalGlutamic AcidHumansHydrogen PeroxideMicroscopy, FluorescenceNeuroprotective AgentsOxidative StressPlant ExtractsPlant LeavesRatsWithaniaAshwagandhaGlutamic AcidHydrogen PeroxideNeuroprotective AgentsPlant Extracts

Identifiers

PMID25789768
PMCPMC4366112
OpenAlexW2049051008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.